Managers / Q2 2025 · view latest →
Green Alpha Advisors, LLC
CIK 0001439207 · 136 2ND AVENUE, UNIT D, NIWOT, CO, 80544 · 3039937856
Summary
Green Alpha Advisors, LLC reported $105M in U.S.-listed holdings across 109 positions for Q2 2025.
Its largest position, IBM, represents 6.2% of the portfolio.
Compared with Q1 2025, the fund opened 0 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 93.0% · $97M
- Other · 6.6% · $7M
- ETP · 0.4% · $379,770
Quarter-over-Quarter Changes full breakdown →
vs Q1 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TWSTTWIST BIOSCIENCE CORP | SOLD OUT | −6.1K | 0 | −$238,073 | $0 |
| REGNREGENERON PHARMACEUTICALS | SOLD OUT | −344 | 0 | −$218,187 | $0 |
| LI-CYCLE HOLDINGS CORP | SOLD OUT | −56.4K | 0 | −$20,350 | $0 |
| CUREVAC N V | TRIMMED | −7.1K | 18.7K | +$30,111 | $101,774 |
| MGXMETAGENOMI INC | TRIMMED | −5.6K | 18.5K | −$5,361 | $27,318 |
| ABCLABCELLERA BIOLOGICS INC | TRIMMED | −8.3K | 29.1K | +$16,309 | $99,823 |
| GHGUARDANT HEALTH INC | TRIMMED | −1.4K | 5.5K | −$9,310 | $285,908 |
| RELYREMITLY GLOBAL INC | TRIMMED | −2.5K | 10.7K | −$73,012 | $200,238 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $102M | 107 | Apr 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $109M | 115 | Jan 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $104M | 102 | Oct 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $105M | 109 | Aug 1, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $94M | 112 | Apr 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $125M | 147 | Jan 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $127M | 141 | Oct 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $124M | 138 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $138M | 142 | Apr 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $139M | 151 | Jan 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $130M | 156 | Oct 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $152M | 153 | Jul 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $143M | 150 | Apr 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $120M | 144 | Jan 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $118M | 141 | Oct 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $435M | 149 | Jul 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $148M | 136 | Apr 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $148M | 124 | Jan 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $145M | 126 | Oct 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $147M | 127 | Jul 22, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.